Table 2.
Characteristic | TID | TIa | TD | |||
---|---|---|---|---|---|---|
White | Black | White | Black | White | Black | |
Patient preference | 2.1% | 3.0% | 1.0% | 2.5% | 5.6% | 6.6% |
Physician preference | 4.4% | 4.0% | 1.0% | 2.0% | 1.2% | 1.0% |
Decline in performance status | 2.5% | 1.0% | 1.1% | 0.5% | 1.9% | 2.0% |
Toxicity | 2.3% | 2.0% | 7.7% | 8.6% | 20.0% | 12.1% |
Progression | 0.1% | 0.0% | 0.6% | 1.0% | 24.4% | 24.2% |
Death | — | — | — | — | 4.1% | 3.0% |
System issues | 1.9% | 2.5% | 0.3% | 1.0% | — | — |
Social reasons | 1.4% | 3.5% | 2.2% | 4.0% | 0.4% | 0.5% |
Insurance related | — | — | 0.3% | 0.0% | — | — |
Other | 6.5% | 6.1% | 5.5% | 6.1% | 2.1% | 3.0% |
aOne reason was reported per treatment interruption; patients could have more than one treatment interruption during the course of therapy.
Abbreviations: TID, treatment initiation delay; TI, treatment interruption; TD, treatment discontinuation.